CIK 0001576280 · Services-Medical Laboratories (SIC 8071) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2019 | FY2018 | |
|---|---|---|---|---|
| Revenue (USD) | 982.0 M | 449.5 M | ||
| Net income (USD) | -75.7 M | -46.1 M | ||
| Diluted EPS (USD/shares) | -3.32 | -6.41 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-19 | 4 | FORM 4 | 2026-10-17 |
| 2026-10-19 | 4 | FORM 4 | 2026-10-15 |
| 2026-10-16 | 144 | 144 | |
| 2026-10-15 | 4 | FORM 4 | 2026-10-14 |
| 2026-10-14 | 144 | 144 | |
| 2026-10-13 | 4 | FORM 4 | 2026-10-12 |
| 2026-10-02 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-02 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-02 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-02 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-02 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-02 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-09-22 | 4 | FORM 4 | 2026-09-21 |
| 2026-09-21 | 4 | FORM 4 | 2026-09-17 |
| 2026-09-17 | 4 | FORM 4 | 2026-09-15 |
| 2026-09-17 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-17 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-17 | 4 | FORM 4 | 2026-09-15 |
| 2026-09-16 | 144 | 144 | |
| 2026-09-16 | 144 | 144 | |
| 2026-09-16 | 144 | 144 | |
| 2026-09-15 | 144 | 144 | |
| 2026-09-14 | 4 | FORM 4 | 2026-09-12 |
Forms on file (last 1,000): 4 685, 144 99, 8-K 80, 10-Q 19, SC 13G/A 18, 3 16, SC 13G 13, SCHEDULE 13G/A 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=GH (0.002 USD), /gw/filings/filings?ticker=GH&form=8-K, /gw/filings/facts?ticker=GH&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange